Last reviewed · How we verify
NCT03167918
Lung Function in Patients With Early Type 2 Diabetes Mellitus
Phase 2, PHASE3 trial testing Calcium Dobesilate in Type 2 Diabetes Mellitus in 200 participants. Completed in 1 May 2017.
1 April 2017
Quick facts
| Lead sponsor | Liaoning University of Traditional Chinese Medicine |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 21 July 2014 |
| Primary completion | 1 April 2017 |
| Estimated completion | 1 May 2017 |
Drugs / interventions tested
- Calcium Dobesilate (CALCIUM DOBESILATE) — full drug profile →
- Xuefuzhuyu Decoction — full drug profile →
- Xuefuzhuyu Decoction & Calcium dobesilate — full drug profile →
- metformin (metformin) — full drug profile →
- Mecobalamin Tablets
Conditions studied
- Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
- Pulmonary Function — all drugs for Pulmonary Function →
Sponsor
Liaoning University of Traditional Chinese Medicine
Who can join
Eligibility, any sex, with Type 2 Diabetes Mellitus or Pulmonary Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the protective effect of calcium dobesilate, Xuefuzhuyu Decoction, calcium dobesilate combined with Xuefuzhuyu Decoction on the early lung function of type 2 diabetes mellitus
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03167918
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Calcium Dobesilate
Trials testing the same drug.
- NCT05305508 — Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19. · Phase 2 · completed
- NCT04283162 — Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy · Phase 4 · unknown
- NCT03962296 — A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon® · Phase 4 · completed
Other recruiting trials for Type 2 Diabetes Mellitus
Currently open trials in the same condition.
- NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
- NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
- NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
- NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
- NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03167918 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liaoning University of Traditional Chinese Medicine
- Last refreshed: 30 May 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03167918.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing